Liberation Daily of medicines: how tender and originally wanted to do?
Ex-factory price is only 15.5 yuan cancer adjuvant asparagus pieces and sold to patients as high as 213 yuan. Recently, the Second Xiangya Hospital of Hunan's "High asparagus film" incident aroused hot.
Local price department investigation found that the price of asparagus pieces "triple jump" is astounding: centralized procurement, the asparagus pieces of guidance prices set at 136 yuan; bidding process, the asparagus pieces of tender value rose to 185.22 yuan; and hospitals were under 15% of the drug addition, the ultimate high of 213 dollars sold to patients.
New drugs to promote medical reform public bidding requirements, to focus on bidding by drugs, uniform distribution, to reduce intermediate links to lower drug prices to ease the people you see a doctor. However, "high Asparagus film" totally to the opposite case.
Drugs in the practice open bidding, the original intention to avoid "runs counter"?
Who is watching the pricing "unrealistically high"
Asparagus pieces 15.5 yuan in the ex-factory price "birth" out of 136 of the guiding price, local price departments are, this is a reference to neighboring provinces, the actual implementation of the 2008 bid price set. Drug guided price in the end it is only reasonable that the approved How?
From the city's head of drugs related to the tender, was informed, drug prices are formulated by the bidding guidance prices. National Development and Reform Commission to have the guide price of drugs, developed with local price levels; of other drugs, according to "quality first, price reasonable" judgments.
Executive president of Shanghai Jiaotong University School of Public Health into the horse, said to be reasonable guidance prices and raw material costs, drug R & D, logistics and distribution expenses and other factors closely related. However, in practice, the necessary cost of drugs and guidance prices, huge gap between the tender price is not uncommon. The reason is that most pharmaceutical companies have to be disguised by agents to achieve bidding, multi-channel link also from profit, driving up drug prices. If the price department negligent, that there will be high on the drug case.
Further problem is that the pricing departments are responsible for pricing, but also entrusted with monitoring the price is "overblown" role "players" "judge" set one. Experts sharply pointed out that self-monitoring system, it is difficult to avoid the high drug baked. Who will monitor pricing "unrealistically high"? This should cause the attention of a new task.
Who is watching the hospital to sell at high prices
Present, 80% of drugs sold through hospitals. Hospital Drug Administration allows up to 15% bonus, "to the medicine could Medicine." However, the asparagus pieces of tender guidance prices from 136 yuan to 213 yuan to sell the hospital to patients, plus more than 56%.
But the industry has pointed out that although the relevant departments of the hospital drug addition there are clearly defined, still can not stop the impulse seeks profit hospitals, hospitals not only not "cold" high drug prices, but "Welcome" high drug prices. Little difference in the choice of a variety of effective drugs, the preferred use of expensive drugs, because the high drug addition, the income of natural increase profits. Although the drugs accounting for 45% of control, but the major hospitals in recent years, total income continued to grow over 10%, in fact, the income from drugs is also growing. In addition to 15%
"Ming buckle" doctors and medical representatives are private, "secret button", which is an open secret. Such as asparagus pieces of sales staff bluntly: high profits, 80% distributed to doctors, medical representatives, 20% left. On the "Dark Button" this blatant bribery, the current authorities and hospital administrators are in the "strike hard", but difficult to obtain evidence, "secret button" still "simmering", became the promotion of expensive drugs behind.
Public oversight of the treatment of collective "blind"
Expensive asparagus slices of "come out", exposing the pharmaceutical industry multi-poor supervision: First, no regulatory guidance prices too high; Second, hospital doctors receiving kickbacks from monitoring; the three pharmaceutical companies in the pharmaceutical Similar acts of commercial bribery on behalf of laissez-faire.
I am an expert from China Manufacturers, usually analyzes all kind of industries situation, such as soya milk maker , oster food processors.
Processing your request, Please wait....
